Efficient mobilization of E1-deleted adenovirus type 5 vectors by wild-type adenoviruses of other serotypes

References

1. Benihoud K., Yeh P., Perricaudet M. 1999; Adenovirus vectors for gene delivery. Current Opinion in Biotechnology 10:440–447
   [Google Scholar]
2. Bernards R., Vaessen M. J., Van der Eb A. J., Sussenbach J. S. 1983; Construction and characterization of an adenovirus type 5/adenovirus type 12 recombinant virus. Virology 131:30–38
   [Google Scholar]
3. Brusca J. S., Chinnadurai G. 1981; Transforming genes among three different oncogenic subgroups of human adenoviruses have similar replicative functions. Journal of Virology 39:300–305
   [Google Scholar]
4. Fallaux F. J., Kranenburg O., Cramer S. J., Houweling A., Van Ormondt H., Hoeben R. C., Van der Eb A. J. 1996; Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Human Gene Therapy 7:215–222
   [Google Scholar]
5. Fallaux F. J., Bout A., Van der Velde I., van den Wollenberg D. J., Hehir K. M., Keegan J., Auger C., Cramer S. J., Van Ormondt H., Van der Eb A. J., Valerio D., Hoeben R. C. 1998; New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Human Gene Therapy 9:1909–1917
   [Google Scholar]
6. Fallaux F. J., Van der Eb A. J., Hoeben R. C. 1999; Who’s afraid of replication-competent adenoviruses?. Gene Therapy 6:709–712
   [Google Scholar]
7. Harvey B. G., Hackett N. R., El Sawy T., Rosengart T. K., Hirschowitz E. A., Lieberman M. D., Lesser M. L., Crystal R. G. 1999; Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. Journal of Virology 73:6729–6742
   [Google Scholar]
8. Hehir K. M., Armentano D., Cardoza L. M., Choquette T. L., Berthelette P. B., White G. A., Couture L. A., Everton M. B., Keegan J., Martin J. M., Pratt D. A., Smith M. P., Smith A. E., Wadsworth S. C. 1996; Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. Journal of Virology 70:8459–8467
   [Google Scholar]
9. Hermens W. T., Verhaagen J. 1997; Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: preferential survival of transduced astroglial cells in nude rats. Human Gene Therapy 8:1049–1063
   [Google Scholar]
10. Hirt B. 1967; Selective extraction of polyoma DNA from infected mouse cell cultures. Journal of Molecular Biology 26:365–369
    [Google Scholar]
11. Horwitz M. S. 1995; Adenoviruses. In Fields Virology pp 2149–2171 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
12. Imler J. L., Bout A., Dreyer D., Dieterle A., Schultz H., Valerio D., Mehtali M., Pavirani A. 1995; Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Human Gene Therapy 6:711–721
    [Google Scholar]
13. Jannun R., Chinnadurai G. 1987; Functional relatedness between the E1a and E1b regions of group C and group D human adenoviruses. Virus Research 7:33–48
    [Google Scholar]
14. Morral N., O’Neal W., Rice K., Leland M., Kaplan J., Piedra P. A., Zhou H., Parks R. J., Velji R., Agullar-Cordova E., Wadsworth S., Graham F. L., Kochanek S., Carey K. D., Beaudet A. L. 1999; Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proceedings of the National Academy of Sciences, USA 96:12816–12821
    [Google Scholar]
15. Roitsch C., Achstetter T., Benchaibi M., Bonfils E., Cauet G., Gloeckler R., L’h te H., Keppi E., Nguyen M., Spehner D., Van Dorsselaer A., Malarme D. 2001; Characterization and quality control of recombinant adenovirus vectors for gene therapy. Journal of Chromatography B Biomedical Science Applications 752:263–280
    [Google Scholar]
16. Van den Heuvel S. J., The S. I., Klein B., Jochemsen A. G., Zantema A., Van der Eb A. J. 1992; p53 shares an antigenic determinant with proteins of 92 and 150 kilodaltons that may be involved in senescence of human cells. Journal of Virology 66:591–595
    [Google Scholar]
17. Zhang W., Low J. A., Christensen J. B., Imperiale M. J. 2001; Role for the adenovirus IVa2 protein in packaging of viral DNA. Journal of Virology 75:10446–10454
    [Google Scholar]